Meptran en es it fr

Meptran Brand names, Meptran Analogs

Meptran Brand Names Mixture

  • No information avaliable

Meptran Chemical_Formula


Meptran RX_link

No information avaliable

Meptran fda sheet

Meptran msds (material safety sheet)

Meptran Synthesis Reference

No information avaliable

Meptran Molecular Weight

309.469 g/mol

Meptran Melting Point

< 25 oC

Meptran H2O Solubility

Soluble as HCl salt

Meptran State


Meptran LogP


Meptran Dosage Forms

Tablets (oral, 1 mg)

Meptran Indication

Used for the symptomatic treatment of parkinsonism.

Meptran Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Meptran Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Meptran side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Meptran Patient Information

Meptran Organisms Affected

Humans and other mammals